Speciation of key arsenic metabolic intermediates in human urine.
about
Microbial methylation of metalloids: arsenic, antimony, and bismuth.The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.Development and application of a robust speciation method for determination of six arsenic compounds present in human urineIn utero arsenic exposure and infant infection in a United States cohort: a prospective studyUrinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, ChinaA novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosolVolatile arsenic species released from Escherichia coli expressing the AsIII S-adenosylmethionine methyltransferase geneInfluence of arsenate and arsenite on signal transduction pathways: an updateInfant toenails as a biomarker of in utero arsenic exposurePhysiologically based pharmacokinetic modeling of arsenic in the mouse.Evaluation of the carcinogenicity of inorganic arsenic.Pathway of human AS3MT arsenic methylation.Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.A disulfide-bond cascade mechanism for arsenic(III) S-adenosylmethionine methyltransferase.Biomarkers of exposure: a case study with inorganic arsenic.Quantitative mass spectrometry reveals the epigenome as a target of arsenic.Carcinogenic and systemic health effects associated with arsenic exposure--a critical review.Preliminary analysis of in utero low-level arsenic exposure and fetal growth using biometric measurements extracted from fetal ultrasound reports.Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.Rice consumption contributes to arsenic exposure in US women.Determination of arsenic species: a critical review of methods and applications, 2000-2003.Environmental distribution, analysis, and toxicity of organometal(loid) compounds.Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT)As(III) S-adenosylmethionine methyltransferases and other arsenic binding proteinsBlood Pressure Changes in Relation to Arsenic Exposure in a U.S. Pregnancy Cohort.Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometryshRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells.Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer).Epigenetic remodeling during arsenical-induced malignant transformation.Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometryBiological and behavioral factors modify urinary arsenic metabolic profiles in a U.S. population.Infant Infections and Respiratory Symptoms in Relation to in Utero Arsenic Exposure in a U.S. Cohort.Arsenic biomethylation by photosynthetic organisms.Maternal arsenic exposure and gestational diabetes and glucose intolerance in the New Hampshire birth cohort study.Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies.The evolving use of arsenic in pharmacotherapy of malignant disease.Extraction tool and matrix effects on arsenic speciation analysis in cell lines.Methylated trivalent arsenic-glutathione complexes are more stable than their arsenite analog.The organoarsenical biocycle and the primordial antibiotic methylarsenite.
P2860
Q24533232-4062BCA5-17E5-4F32-92E5-414B32927E45Q24812468-3654CC4B-CABD-44B5-9BD0-CA7B410C3BB8Q24813763-F07014D7-9EBF-4487-A3D9-764A656A569AQ28390228-34C855F9-196C-4D78-ADA4-B3BC239FDBDFQ28395532-037E9DFA-8C01-49D5-801B-19F39956685CQ28584169-72EBCE8F-B581-4690-BEC4-F5A269D2A9D9Q30666566-74F36E35-8B78-4EFD-AAA3-83B97D299CDEQ34024633-0E57C7DA-15B8-48A5-9C95-8E5F29EB6CD9Q34076326-A0675830-28D1-43C0-B68F-3CE2D2BD7660Q34282733-3D76727E-025E-4337-9E67-BE4993F351AFQ34371580-E632459E-4D19-411D-9336-8069F1A14EDEQ34444053-EFAC248F-E966-40BD-884E-66A2345D0E42Q34567906-DDFB62DF-5D2C-4B6C-94C1-A3B4239445F4Q35167673-CD4AFA45-02B1-4D97-A83C-6C3D18F915D0Q35173252-B3FA6E1C-CEBC-485D-A9D0-1D702EDC15A9Q35180456-EBC3E44F-34D7-480D-B176-BE41322D2948Q35571581-995153C3-BC9D-4D2C-88E9-1378351F5782Q35601304-A847418F-B7FB-4404-8B10-15EEC89A075AQ35633033-E7E83613-AC0E-4FE0-A11F-7B4344D4BD0FQ35651235-06BBA582-B574-408F-A74B-CE7EFE973A38Q35759588-A682C97A-B44E-4D6C-B6C6-63CFFD5DDFD0Q35828728-5F638279-96F9-4FFA-8B4E-B04D9AE2EDC6Q35844220-C68F3232-212B-4C7F-9EAD-291BFB1EE340Q36042152-34F47096-CC13-46AF-AB15-B950A25A5474Q36112021-02647818-C839-4B7A-9FFE-8B187438BFB8Q36566386-2319E110-9191-46C4-95AA-DB946CA20589Q36579671-B8D1E107-E6D7-4B19-ACCE-40C8707770D4Q36589316-113D1B4D-6DA2-4874-9801-6D7D211771D6Q36803731-607A157B-2DA4-4520-98E4-D9448662DF18Q36838009-4D3BA5BA-180D-4EC3-9159-8BC5F79CD70DQ36849184-AF076159-3CEC-495D-A0CC-9DCD98712D54Q36937175-8E81C010-AE2D-4AE0-ADB5-0464452ACC57Q36968136-FC670109-8A1D-4546-8EBA-667D195E393FQ37086650-20FB3B0C-F33C-44BB-9571-FDD250CB9B23Q37402890-615AC401-311D-46F0-8586-A9FCF1CE646BQ37609470-EAE8555D-EFA5-49C6-AEDC-5B55A500B205Q38089629-A857F51C-20FC-4647-B9A6-57F37F98E791Q38603464-6A3DDA51-77FC-4C97-9767-F1E14C436274Q38620066-4B961B2C-6E95-4022-A7E0-D199C50A63B7Q38978392-8BA8D475-D2D5-44DF-B1CD-A96D77DA10D4
P2860
Speciation of key arsenic metabolic intermediates in human urine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Speciation of key arsenic metabolic intermediates in human urine.
@ast
Speciation of key arsenic metabolic intermediates in human urine.
@en
type
label
Speciation of key arsenic metabolic intermediates in human urine.
@ast
Speciation of key arsenic metabolic intermediates in human urine.
@en
prefLabel
Speciation of key arsenic metabolic intermediates in human urine.
@ast
Speciation of key arsenic metabolic intermediates in human urine.
@en
P2093
P356
P1433
P1476
Speciation of key arsenic metabolic intermediates in human urine
@en
P2093
P304
P356
10.1021/AC000527U
P407
P50
P577
2000-11-01T00:00:00Z